By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – CapitalBio has been certified under the Roche NimbleGen Certified Service Provider program, Roche NimbleGen said today.

Under the program, CapitalBio has been certified to process customer samples for Roche NimbleGen's gene expression, comparative genomic hybridization and copy number variation, and DNA methylation services in CapitalBio's Beijing lab.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.